pubmed-article:10399596 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10399596 | lifeskim:mentions | umls-concept:C0008269 | lld:lifeskim |
pubmed-article:10399596 | lifeskim:mentions | umls-concept:C0312418 | lld:lifeskim |
pubmed-article:10399596 | lifeskim:mentions | umls-concept:C0056751 | lld:lifeskim |
pubmed-article:10399596 | lifeskim:mentions | umls-concept:C0032150 | lld:lifeskim |
pubmed-article:10399596 | lifeskim:mentions | umls-concept:C0370215 | lld:lifeskim |
pubmed-article:10399596 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:10399596 | lifeskim:mentions | umls-concept:C0036667 | lld:lifeskim |
pubmed-article:10399596 | lifeskim:mentions | umls-concept:C0016910 | lld:lifeskim |
pubmed-article:10399596 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:10399596 | pubmed:dateCreated | 1999-7-29 | lld:pubmed |
pubmed-article:10399596 | pubmed:abstractText | The in vitro susceptibility of 91 Plasmodium falciparum isolates obtained from malaria-infected children living near Libreville (Gabon) was evaluated against chloroquine and cycloguanil (biologically active metabolite of proguanil), using an isotopic micro-drug susceptibility test. In vitro resistance to chloroquine and cycloguanil was observed in 83% (35/42) and in 38% (30/78) of the patients, respectively. Our data showed that 41% (16/39) of Gabonese field isolates were resistant both to chloroquine and cycloguanil. These findings are of great importance because they might indicate imminent chloroquine-proguanil failure, and there are not many affordable antimalarial drugs to replace chloroquine-proguanil combination. | lld:pubmed |
pubmed-article:10399596 | pubmed:language | fre | lld:pubmed |
pubmed-article:10399596 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10399596 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10399596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10399596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10399596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10399596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10399596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10399596 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10399596 | pubmed:month | May | lld:pubmed |
pubmed-article:10399596 | pubmed:issn | 0037-9085 | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:RogierCC | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:LebeauCC | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:KombilaMM | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:ParzyDD | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:KeundjianAA | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:Owono... | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:PradinesBB | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:FusaiTT | lld:pubmed |
pubmed-article:10399596 | pubmed:author | pubmed-author:Mabika... | lld:pubmed |
pubmed-article:10399596 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10399596 | pubmed:volume | 92 | lld:pubmed |
pubmed-article:10399596 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10399596 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10399596 | pubmed:pagination | 91-4 | lld:pubmed |
pubmed-article:10399596 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:meshHeading | pubmed-meshheading:10399596... | lld:pubmed |
pubmed-article:10399596 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10399596 | pubmed:articleTitle | [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil]. | lld:pubmed |
pubmed-article:10399596 | pubmed:affiliation | Unité de parasitologie, Institut de médecine tropicale du Service de santé des armées, Marseille, France. | lld:pubmed |
pubmed-article:10399596 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10399596 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:10399596 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10399596 | lld:pubmed |